BMS Scales AI Across Drug Discovery
Bristol Myers Squibb is expanding its NVIDIA collaboration with a second DGX SuperPOD built on eight Vera Rubin NVL72 systems. The infrastructure is intended to make large-scale AI broadly available across BMS research, from…
